SCHEMBL767309

SCHEMBL767309

CC(C)C(=O)Nc1nc(Oc2cc(Cl)ccc2Cl)c2[nH]cnc2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 1/20 0.39
CDK2 P24941 6/20 0.38
CCR4 P51679 2/20 0.38
POLA1 P09884 1/20 0.36
CDK1 P06493 4/20 0.36
CCNB1 P14635 4/20 0.36
CCNB2 O95067 3/20 0.36
CCNA2 P20248 3/20 0.36
CCNA1 P78396 3/20 0.36
CCNB3 Q8WWL7 3/20 0.36
LRRK2 Q5S007 1/20 0.36
ADORA1 P30542 1/20 0.36
PDPK1 O15530 1/20 0.36
CCNT1 O60563 1/20 0.36
CDK7 P50613 1/20 0.36
CDK9 P50750 1/20 0.36
CCNH P51946 1/20 0.36
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL767308 0.85 LMNA (0.38) ADORA1LMNATSHRMAPK1GPBAR1
SCHEMBL4307867 0.77 DPP4 (0.49) STAT3POLA1ADORA1LMNA
SCHEMBL4777463 0.73 GDA (0.42) STAT3CDK2CDK1CCNB1CCNB2
SCHEMBL9412467 0.66 DPP4 (0.50) STAT3POLA1
SCHEMBL19728689 0.64 CDK2 (0.48) CDK2POLA1CDK1CCNB1ADORA1
SCHEMBL29665061 0.63 ADORA1 (0.40) CDK2ADORA1LMNATSHR
SCHEMBL5483576 0.63 ADORA1 (0.40) CDK2ADORA1LMNATSHR
SCHEMBL9412617 0.63 GDA (0.39) STAT3
SCHEMBL5197101 0.63 GDA (0.54) STAT3POLA1
SCHEMBL14254815 0.63 LMNA (0.62) LMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140179875-A1 SULFURIZATION REAGENTS ON SOLID SUPPORTS GIRINDUS AMERICA, INC. (US) 2014-06-26 US disclosed
WO-2013017469-A1 SULFURIZATION REAGENTS ON SOLID SUPPORTS GIRINDUS AMERICA, INC. (US) 2013-02-07 WO disclosed
US-20120071640-A1 Sulfurizing reagents and their use for oligonucleotides synthesis GIRINDUS AMERICA, INC. (US) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071640-A1 Sulfurizing reagents and their use for oligonucleotides synthesis RRM1, SRRT, NSUN2 STAT3 4406/4885CDK2 2814/4885CCR4 2162/4885
US-20140179875-A1 SULFURIZATION REAGENTS ON SOLID SUPPORTS OR10J3, RPS8, NSUN2 STAT3 2635/4885CDK2 1837/4885CCR4 517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.